F Swan

3.9k total citations · 1 hit paper
55 papers, 3.2k citations indexed

About

F Swan is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, F Swan has authored 55 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pathology and Forensic Medicine, 25 papers in Oncology and 16 papers in Genetics. Recurrent topics in F Swan's work include Lymphoma Diagnosis and Treatment (46 papers), Chronic Lymphocytic Leukemia Research (16 papers) and CNS Lymphoma Diagnosis and Treatment (14 papers). F Swan is often cited by papers focused on Lymphoma Diagnosis and Treatment (46 papers), Chronic Lymphocytic Leukemia Research (16 papers) and CNS Lymphoma Diagnosis and Treatment (14 papers). F Swan collaborates with scholars based in United States, Belgium and Canada. F Swan's co-authors include Fernando Cabanillas, Peter McLaughlin, Fredrick B. Hagemeister, Maria Alma Rodriguez, Jorge Romaguera, William S. Velasquez, J R Redman, FB Hagemeister, Sundar Jagannath and JR Redman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

F Swan

55 papers receiving 3.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

1988 487 citations Fernando Cabanillas, Peter McLaughlin et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
F Swan	2.5k	1.7k	1.1k	760	538	55	3.2k
William S. Velasquez	2.5k 1.0×	1.4k 0.8×	1.3k 1.3×	638 0.8×	597 1.1×	58	3.5k
Y Bastion	2.5k 1.0×	1.6k 1.0×	1.2k 1.1×	613 0.8×	346 0.6×	47	3.2k
Frederick Hagemeister	2.3k 0.9×	1.7k 1.0×	1.0k 1.0×	470 0.6×	603 1.1×	69	3.3k
José Thomas	3.3k 1.3×	1.5k 0.9×	1.1k 1.0×	1.2k 1.6×	1.2k 2.3×	77	4.3k
Marcel Reiser	2.5k 1.0×	1.9k 1.1×	1.3k 1.2×	714 0.9×	519 1.0×	124	3.6k
B Coiffier	3.7k 1.5×	2.4k 1.4×	1.4k 1.3×	1.0k 1.3×	564 1.0×	43	4.4k
Christophe Fermé	3.7k 1.5×	2.4k 1.4×	1.2k 1.1×	1.3k 1.7×	617 1.1×	98	4.3k
Andreas H. Sarris	2.4k 1.0×	1.5k 0.9×	1.0k 1.0×	488 0.6×	416 0.8×	67	3.3k
Luigi Rigacci	3.1k 1.3×	1.6k 0.9×	809 0.8×	974 1.3×	798 1.5×	144	4.0k
Jehan Dupuis	3.1k 1.3×	1.8k 1.0×	926 0.9×	729 1.0×	617 1.1×	115	4.1k

Countries citing papers authored by F Swan

Since Specialization

Citations

This map shows the geographic impact of F Swan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Swan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Swan more than expected).

Fields of papers citing papers by F Swan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Swan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Swan. The network helps show where F Swan may publish in the future.

Co-authorship network of co-authors of F Swan

This figure shows the co-authorship network connecting the top 25 collaborators of F Swan. A scholar is included among the top collaborators of F Swan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Swan. F Swan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hecht, J. Randolph, Madhavan V. Pillai, Russell Gollard, et al.. (2010). A Randomized, Placebo-Controlled Phase II Study Evaluating the Reduction of Neutropenia and Febrile Neutropenia in Patients With Colorectal Cancer Receiving Pegfilgrastim With Every-2-Week Chemotherapy. Clinical Colorectal Cancer. 9(2). 95–101. 50 indexed citations

Sarris, A H, Anas Younes, Peter McLaughlin, et al.. (1996). Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 14(1). 233–239. 32 indexed citations

Seymour, John F., Peter McLaughlin, Lillian M. Fuller, et al.. (1996). High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma. Annals of Oncology. 7(2). 157–163. 23 indexed citations

Rodríguez, Maritza, Fernando Cabanillas, William S. Velasquez, et al.. (1995). Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.. Journal of Clinical Oncology. 13(7). 1734–1741. 88 indexed citations

Swan, F, Susan L. Tucker, Herbert A. Fritsche, et al.. (1995). Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase. Leukemia & lymphoma. 18(1-2). 87–92. 18 indexed citations

Hagemeister, Fredrick B., Donald A. Podoloff, Maria Alma Rodriguez, et al.. (1994). The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy. Annals of Oncology. 5. S59–S63. 34 indexed citations

Younes, Ahmed, Johannes Drach, Ruth L. Katz, et al.. (1994). Growth inhibition of follicular small-cleaved-cell lymphoma cells in short-term culture by interleukin-3. Annals of Oncology. 5(3). 265–268. 9 indexed citations

Velasquez, William S., Lillian M. Fuller, Pamela K. Allen, et al.. (1994). Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin-vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis. Cancer. 73(9). 2408–2416. 14 indexed citations

McLaughlin, Peter, Fredrick B. Hagemeister, F Swan, et al.. (1994). Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.. Journal of Clinical Oncology. 12(3). 575–579. 77 indexed citations

10.

Hagemeister, Fredrick B., Pamela K. Allen, Peter McLaughlin, et al.. (1994). Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas. Annals of Oncology. 5. S41–S46. 52 indexed citations

11.

Preti, A., Fredrick B. Hagemeister, Peter McLaughlin, et al.. (1994). Hodgkin's disease with a mediastinal mass greater than 10 cm: Results of four different treatment approaches. Annals of Oncology. 5. S97–S100. 12 indexed citations

12.

Rodriguez, Maria Alma, Lillian M. Fuller, Stuart O. Zimmerman, et al.. (1993). Hodgkin's disease: Study of treatment intensities and incidences of second malignancies. Annals of Oncology. 4(2). 125–131. 63 indexed citations

13.

Dimopoulos, Meletios Α., Fernando Cabanillas, J. Jack Lee, et al.. (1993). Prognostic role of serum beta 2-microglobulin in Hodgkin's disease.. Journal of Clinical Oncology. 11(6). 1108–1111. 42 indexed citations

14.

Rodríguez, José, Fernando Cabanillas, Peter McLaughlin, et al.. (1992). Original article: A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the ‘tumor score’. Annals of Oncology. 3(9). 711–717. 83 indexed citations

15.

Woo, Shiao Y., Lillian M. Fuller, Jackson Cundiff, et al.. (1992). Radiotherapy during pregnancy for clinical stages IA–IIA Hodgkin's disease. International Journal of Radiation Oncology*Biology*Physics. 23(2). 407–412. 93 indexed citations

16.

Hagemeister, Fredrick B., Paul McLaughlin, Maria Alma Rodriguez, et al.. (1992). NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis. Annals of Oncology. 3. S87–S90. 17 indexed citations

17.

Swan, F, Fernando Cabanillas, Susan L. Tucker, et al.. (1991). Prognostic Value of Serum β-2 Microglobulin in Low-Grade Lymphoma. Annals of Internal Medicine. 114(10). 855–860. 82 indexed citations

18.

Robertson, L. E., J R Redman, James J. Butler, et al.. (1991). Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse.. Journal of Clinical Oncology. 9(2). 236–242. 57 indexed citations

19.

Cabanillas, Fernando, Sen Pathak, Grace Grant, et al.. (1989). Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma. The American Journal of Medicine. 87(2). 167–172. 58 indexed citations

20.

Swan, F, William S. Velasquez, S. C. Tucker, et al.. (1989). A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.. Journal of Clinical Oncology. 7(10). 1518–1527. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact